Stay updated with breaking news from Oncoextra Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Resources Investment Advisors LLC. trimmed its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 96,686 shares of the medical research company’s stock after selling 3,507 shares during the period. Resources Investment Advisors […]
Investment analysts at StockNews.com assumed coverage on shares of Exact Sciences (NASDAQ:EXAS – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “hold” rating on the medical research company’s stock. Several other equities analysts have also issued reports on EXAS. The Goldman Sachs Group boosted their […]
Connor Clark & Lunn Investment Management Ltd. bought a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 159,951 shares of the medical research company’s stock, valued at approximately $10,846,000. Connor Clark […]
Connor Clark & Lunn Investment Management Ltd. acquired a new position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 159,951 shares of the medical research company’s stock, valued at approximately $10,846,000. Other institutional investors and […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) insider Brian Baranick sold 1,350 shares of the stock in a transaction on Monday, August 7th. The shares were sold at an average price of $85.04, for a total value of $114,804.00. Following the transaction, the insider now directly owns 8,871 shares of the company’s stock, valued […]